Hyperhidrosis or excessive sweating.
Armpits. Hands. Feet.

Tratamiento con bótox para la hiperhidrosis, o sudoración excesiva. Centro de Medicina Estética en Barcelona, Doctora Escoda

Neuromodulatory treatment is a non-surgical alternative with proven efficacy for hyperhidrosis or excessive sweating.

Book an appointment!

What is hyperhidrosis?

Hyperhidrosis, or excessive sweating, is a poorly adapted phenomenon in which an abnormally higher amount of sweat is secreted than is required for normal thermal balance. Sometimes it can exceed the normal amount by up to 40 times. It can cause considerable emotional stress, making it difficult for the patient’s personal, work and social life, and even preventing acts such as shaking hands. A quantitative definition of hyperhidrosis would be the secretion of more than 50 mg of sweat per minute.

Hyperhidrosis is caused by an overactivity of the ecrin glands, mainly the armpits, hands and feet. The most common form is ideopathy.

What are the treatments for hyperhidrosis?

Traditional therapies used to treat hyperhidrosis are numerous, often unhelpful and rewarding. The treatment should aim to improve the social discomfort of the patient.

The most novel treatment that has been imposed in recent years for severe focal hyperhidrosis is chemical skin denervation. It offers a safe alternative to surgical treatments, and an option to those hyperhidrosis resistant to topical treatments.

By acting on motor neurons, it blocks the secretion of acetylcholine to peripheral cholinergic synapses and blocks neurotransmission. Inhibiting the release of acetylcholine blocks the innervation of the ecrine gland and decreases sweating.

This is the treatment for excessive sweating .

Application of treatment for hyperhidrosis

Application of treatment for hyperhidrosis

The onset of the anhydrous effect begins to be noticed 24-48h after treatment and the maximum response is reached within 7 days.

The average duration of the anhydrous effect is 4-6 months, although the effectiveness of the second treatment at 6 months is usually greater as there is a cumulative effect.

Counter-indications

  • Pregnant patients
  • Patients with hypersensitivity to any of its components: TB, human albumin or saline solution
  • Neuromuscular disorders or medications that may block neuromuscular binding or clotting disorders


Not to be co-administered with aminoglucosides